Author:
Di Leo Angelo,Isola Jorma
Reference53 articles.
1. Polychemotherapy for early breast cancer: an overview of the randomised trials;Early Breast Cancer Trialists' Collaborative Group;Lancet,1998
2. CMF versus CAF with and without tamoxifen in high-risk node negative breast cancer patients and a natural history follow-up study in low-risk node negative patients: first results of Intergroup trial INT 0102;Hutchins;Proc Am Soc Clin Oncol,1998
3. Adjuvant anthracycline in breast cancer. Improved outcome in premenopausal patients following substitution of methotrexate in the CMF combination with epirubicin;Mouridsen;Proc Am Soc Clin Oncol,1999
4. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.
5. Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer;Piccart;J Clin Oncol,2001
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献